Gene · 7732
Papers1,998
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,998
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New AAV tools fail to detect Neurod1-mediated neuronal conversion of Müller glia and astrocytes in vivo. | EBioMedicine | 2023 | 36947961 | PubTator, text mining | PubMed |
| Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription. | Blood | 2023 | 36947815 | PubTator, text mining | PubMed |
| Opto-APC: Engineering of cells that display phytochrome B on their surface for optogenetic studies of cell-cell interactions. | Front Mol Biosci | 2023 | 36936981 | PubTator, text mining | PubMed |
| Precise programming of multigene expression stoichiometry in mammalian cells by a modular and programmable transcriptional system. | Nat Commun | 2023 | 36932109 | PubTator, text mining | PubMed |
| The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma. | Blood Adv | 2023 | 36920785 | PubTator, text mining | PubMed |
| Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons. | Mol Cell | 2023 | 36917981 | PubTator, text mining | PubMed |
| A rationally designed optochemogenetic switch for activating canonical Wnt signaling. | iScience | 2023 | 36915690 | PubTator, text mining | PubMed |
| In search of an ideal template for therapeutic genome editing: A review of current developments for structure optimization. | Front Genome Ed | 2023 | 36911237 | PubTator, text mining | PubMed |
| Research Progresses and Applications of Fluorescent Protein Antibodies: A Review Focusing on Nanobodies. | Int J Mol Sci | 2023 | 36901737 | PubTator, text mining | PubMed |
| TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | Mol Cell | 2023 | 36898370 | PubTator, text mining | PubMed |
| Syncytin-mediated open-ended membrane tubular connections facilitate the intercellular transfer of cargos including Cas9 protein. | Elife | 2023 | 36896791 | PubTator, text mining | PubMed |
| Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis. | Cell Death Differ | 2023 | 36894688 | PubTator, text mining | PubMed |
| Visualizing cell-cell communication using synthetic notch activated MRI. | Proc Natl Acad Sci U S A | 2023 | 36893267 | PubTator, text mining | PubMed |
| Altered DNA repair pathway engagement by engineered CRISPR-Cas9 nucleases. | Proc Natl Acad Sci U S A | 2023 | 36881621 | PubTator, text mining | PubMed |
| A chemically controlled Cas9 switch enables temporal modulation of diverse effectors. | Nat Chem Biol | 2023 | 36879061 | PubTator, text mining | PubMed |
| Enhanced single RNA imaging reveals dynamic gene expression in live animals. | Elife | 2023 | 36867026 | PubTator, text mining | PubMed |
| GJB4 variants linked to skin disease exhibit a trafficking deficiency en route to gap junction formation that can be restored by co-expression of select connexins. | Front Cell Dev Biol | 2023 | 36861039 | PubTator, text mining | PubMed |
| An arrayed CRISPR screen of primary B cells reveals the essential elements of the antibody secretion pathway. | Front Immunol | 2023 | 36860866 | PubTator, text mining | PubMed |
| H3K4me3 regulates RNA polymerase II promoter-proximal pause-release. | Nature | 2023 | 36859550 | PubTator, text mining | PubMed |
| The Tardigrade damage suppressor protein Dsup promotes DNA damage in neurons. | Mol Cell Neurosci | 2023 | 36858083 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7732/papers?page=19